Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""neoplasms"" wg kryterium: Temat


Tytuł :
Flat-based over-the-scope clip-assisted endoscopic full-thickness resection of a duodenal neuroendocrine tumour: a safe alternative to endoscopic submucosal dissection.
Autorzy :
Sonthalia N; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Shah BB; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Goenka MK; Institute of Gastrosciences and Liver diseases, Apollo Gleneagles Hospital, Kolkata, India.
Pokaż więcej
Źródło :
Endoscopy [Endoscopy] 2022 Jul; Vol. 54 (7), pp. E391-E393. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Journal Article
MeSH Terms :
Duodenal Neoplasms*/surgery
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/surgery
Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Endoscopic resection of a duodenal neuroendocrine tumor.
Autorzy :
Furukawa K; Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan.
Nakamura M; Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan.
Kawashima H; Endoscopy, Nagoya University Hospital, Japan.
Fujishiro M; Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan.
Pokaż więcej
Źródło :
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva [Rev Esp Enferm Dig] 2022 May; Vol. 114 (5), pp. 291-292.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Duodenal Neoplasms*/diagnostic imaging
Duodenal Neoplasms*/pathology
Duodenal Neoplasms*/surgery
Neuroendocrine Tumors*/diagnostic imaging
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*
Endoscopy, Gastrointestinal/methods ; Female ; Humans ; Intestinal Neoplasms ; Middle Aged ; Pancreatic Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study.
Autorzy :
Esposito G; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Cazzato M; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Rinzivillo M; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy.
Pilozzi E; Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy.
Lahner E; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Annibale B; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Panzuto F; Digestive Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, ENETS Center of Excellence, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2022 Jul; Vol. 54 (7), pp. 890-895. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji :
Journal Article
MeSH Terms :
Colonic Polyps*/pathology
Endoscopic Mucosal Resection*
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Colonoscopy ; Gastric Mucosa/pathology ; Gastroscopy/methods ; Humans ; Intestinal Neoplasms ; Neoplasm Recurrence, Local/pathology ; Neuroendocrine Tumors ; Pancreatic Neoplasms ; Prospective Studies ; Retrospective Studies ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Double-endoscope assisted endoscopic submucosal dissection for treating gastric neuroendocrine tumor.
Autorzy :
Lu J; School of Medicine, Shandong University, Jinan, Shandong, China.; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Wang P; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Ji R; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Lu X; Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło :
Endoscopy [Endoscopy] 2022 Jul; Vol. 54 (7), pp. E342-E343. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Endoscopes ; Gastric Mucosa/pathology ; Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.
Autorzy :
Cha B; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Shin J; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Ko WJ; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Kwon KS; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea.
Kim H; Department of Internal Medicine, Digestive Disease Center, Inha University School of Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon, 400-711, Republic of Korea. .
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2022 Jun 09; Vol. 22 (1), pp. 293. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji :
Journal Article
MeSH Terms :
Endoscopic Mucosal Resection*
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Rectal Neoplasms*/pathology
Rectal Neoplasms*/surgery
Endoscopes ; Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Prognosis ; Retrospective Studies ; Stomach Neoplasms ; Treatment Outcome
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
[Incidental Finding of Appendiceal Neuroendocrine Tumour].
Autorzy :
Thomas M; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Wahba R; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Chiapponi C; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Stippel DL; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Bruns C; Klinik für Viszeral-, Allgemeine-, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln, Koln, Deutschland.
Pokaż więcej
Transliterated Title :
Zufallsbefund NEN Appendix.
Źródło :
Zentralblatt fur Chirurgie [Zentralbl Chir] 2022 Jun; Vol. 147 (3), pp. 244-248. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Appendiceal Neoplasms*/diagnosis
Appendiceal Neoplasms*/pathology
Appendiceal Neoplasms*/surgery
Appendicitis*/diagnosis
Appendicitis*/pathology
Appendicitis*/surgery
Appendix*/pathology
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Appendectomy ; Humans ; Incidental Findings ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Clinicopathological characteristics and survival outcomes of patients with gallbladder neuroendocrine tumor.
Autorzy :
Tan Q; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Wang X; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Li Y; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China.
Tan C; Department of Pancreatic Surgery, West China Hospital, Sichuan University, China. Electronic address: .
Pokaż więcej
Źródło :
Asian journal of surgery [Asian J Surg] 2022 Jun; Vol. 45 (6), pp. 1358-1360. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma, Neuroendocrine*
Gallbladder Neoplasms*/pathology
Gallbladder Neoplasms*/surgery
Neuroendocrine Tumors*/surgery
Humans ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Prognosis ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Opinia redakcyjna
Tytuł :
Primary vitreoretinal involvement and immunopositivity for BRAFV600E help distinguish metastatic from primary intraocular melanoma: a detailed histopathologic study of metastatic cutaneous melanoma to the eye.
Autorzy :
Neerukonda VK; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Kim IK; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.; Vitreoretinal Surgery Service, Massachusetts Eye and Ear, Boston, MA, USA.
Stagner AM; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2022 Jun; Vol. 80 (7), pp. 1061-1070. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Eye Neoplasms*/diagnosis
Eye Neoplasms*/genetics
Eye Neoplasms*/secondary
Melanoma*/diagnosis
Melanoma*/genetics
Melanoma*/secondary
Proto-Oncogene Proteins B-raf*/genetics
Skin Neoplasms*/diagnosis
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Diagnosis, Differential ; Humans ; Retrospective Studies ; Uveal Neoplasms/diagnosis ; Uveal Neoplasms/genetics ; Uveal Neoplasms/pathology
SCR Disease Name :
Melanoma, Cutaneous Malignant; Uveal melanoma
Czasopismo naukowe
Tytuł :
The HER family as therapeutic targets in colorectal cancer.
Autorzy :
Ye P; Department of Anatomy and Histology, School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China. Electronic address: .
Wang Y; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Li R; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Chen W; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Wan L; School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China.
Cai P; Department of Anatomy and Histology, School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Jun; Vol. 174, pp. 103681. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
ErbB Receptors*/drug effects
ErbB Receptors*/metabolism
Breast Neoplasms/drug therapy ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Female ; Humans ; Lung Neoplasms ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptor, ErbB-3/metabolism
Czasopismo naukowe
Tytuł :
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors.
Autorzy :
Ruffini E; University of Torino, Torino, Italy. Electronic address: .
Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.
Huang J; Memorial Sloan Kettering Cancer Center, New York, New York.
Ahmad U; Cleveland Clinic, Cleveland, Ohio.
Appel S; Sheba Medical Center, Ramat Gan, Israel.
Bille A; Guy's Hospital, London, United Kingdom.
Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco.
Brambilla C; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey.
Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
Detterbeck F; Yale University School of Medicine, New Haven, Connecticut.
Falkson C; Queen's University in Kingston, Ontario, Canada.
Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
Filosso PL; University of Torino, Torino, Italy.
Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.
Girard N; Institut Curie, Paris, France.
Guerrera F; University of Torino, Torino, Italy.
Infante M; University and Hospital Trust, Verona, Italy.
Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Marino M; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Marom EM; University of Tel Aviv, the Chaim Sheba Medical Center, Tel Aviv, Israel.
Nicholson AG; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York.
Simone CB 2nd; Memorial Sloan Kettering Cancer Center, New York, New York.
Asamura H; Keio University, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
IASLC Staging and Prognostic Factors Committee and of the Advisory Boards
Źródło :
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. 838-851. Date of Electronic Publication: 2022 Mar 20.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Staging*/classification
Neoplasm Staging*/methods
Neoplasms, Glandular and Epithelial*/classification
Neoplasms, Glandular and Epithelial*/pathology
Thymus Neoplasms*/classification
Thymus Neoplasms*/pathology
Humans ; Lung Neoplasms/classification ; Lung Neoplasms/pathology ; Prognosis
SCR Disease Name :
Thymic epithelial tumor
Czasopismo naukowe
Tytuł :
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.
Autorzy :
Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Higano CS; Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington.
de Bono JS; Drug Development Unit, The Institute of Cancer Research and Royal Marsden, London, United Kingdom.
Cook N; The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.
Rathkopf DE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York.
Wisinski KB; Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.
Martin-Liberal J; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
Linch M; University College London (UCL) Cancer Institute and UCL Hospital, London, United Kingdom.
Heath EI; Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Baird RD; Cancer Research UK Cambridge Center, Cambridge, United Kingdom.
García-Carbacho J; Department of Medical Oncology (Hospital Clinic Barcelona)/Translational Genomics and Targeted Therapies in Solid Tumors (IDIBAPS), Barcelona, Spain.
Quintela-Fandino M; Hospital Universitario, Quiron Madrid, Madrid, Spain.
Barry ST; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
de Bruin EC; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Colebrook S; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Hawkins G; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Klinowska T; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Maroj B; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Moorthy G; Clinical Pharmacology & Quantitative Pharmacology (CPQP), Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, Massachusetts.
Mortimer PG; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Moschetta M; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Nikolaou M; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Sainsbury L; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 01; Vol. 28 (11), pp. 2257-2269.
Typ publikacji :
Clinical Trial, Phase I; Journal Article
MeSH Terms :
Aniline Compounds*/adverse effects
Chromones*/adverse effects
Neoplasms*/drug therapy
Neoplasms*/pathology
Abiraterone Acetate/therapeutic use ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/etiology ; Humans ; Lung Neoplasms/drug therapy ; Male ; Prednisone/therapeutic use ; Prostate-Specific Antigen ; Prostatic Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy.
Autorzy :
Zhu C; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Kawachi H; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Lu X; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China. .
Pokaż więcej
Źródło :
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2022 May; Vol. 25 (3), pp. 659-664. Date of Electronic Publication: 2022 Feb 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Adult ; Endoscopy, Gastrointestinal ; Gastric Mucosa/pathology ; Humans ; Intestinal Neoplasms ; Ki-67 Antigen/analysis ; Male ; Pancreatic Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
PET Imaging of Estrogen Receptors for Gynecological Tumors.
Autorzy :
Tsujikawa T; From the Biomedical Imaging Research Center.
Makino A; From the Biomedical Imaging Research Center.
Mori T; From the Biomedical Imaging Research Center.
Tsuyoshi H; Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Kiyono Y; From the Biomedical Imaging Research Center.
Yoshida Y; Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Okazawa H; From the Biomedical Imaging Research Center.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2022 Jul 01; Vol. 47 (7), pp. e481-e488. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Endometrial Neoplasms*/diagnostic imaging
Genital Neoplasms, Female*/diagnostic imaging
Positron-Emission Tomography*/methods
Receptors, Estrogen*
Breast Neoplasms ; Estradiol ; Estrogens ; Female ; Fluorodeoxyglucose F18 ; Humans
Czasopismo naukowe
Tytuł :
Sensitive and specific detection of breast cancer lymph node metastasis through dual-modality magnetic particle imaging and fluorescence molecular imaging: a preclinical evaluation.
Autorzy :
Wang G; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Li W; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Shi G; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; University of Science and Technology of China, Hefei, 230026, China.
Tian Y; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; Medical School of Chinese PLA, Beijing, 100853, China.
Kong L; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Ding N; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Lei J; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Jin Z; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China. jin_.
Tian J; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. .; University of Chinese Academy of Sciences, Beijing, 100080, China. .; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, 100083, China. .
Du Y; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. .; University of Chinese Academy of Sciences, Beijing, 100080, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (8), pp. 2723-2734. Date of Electronic Publication: 2022 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Magnetite Nanoparticles*/chemistry
Neoplasms, Second Primary*
Adenosine Triphosphate ; Animals ; Contrast Media ; Female ; Humans ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Lymphatic Metastasis/diagnostic imaging ; Lymphatic Metastasis/pathology ; Magnetic Resonance Imaging/methods ; Melanoma ; Mice ; Skin Neoplasms ; Tumor Microenvironment
SCR Disease Name :
Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł :
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Autorzy :
Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany. Electronic address: .
Kluck K; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Kirchner M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Lüders H; Department of Pneumology, Protestant Lung Hospital, Berlin, Germany.
Roeper J; Department of Hematology and Oncology, Pius-Hospital, University Dept. of Internal Medicine - Oncology, Oldenburg, Germany.
Falkenstern-Ge RF; Department of Thoracic Oncology, Robert Bosch Center for Tumor Diseases (RBCT), 70376 Stuttgart, Germany.
Szewczyk M; Department of Pneumology, Lungenclinic Großhansdorf, Großhansdorf, Germany.
Sticht F; Clinic and Polyclinic for Internal Medicine II, University Hospital Regensburg, 93042 Regensburg, Germany.
Saalfeld FC; Clinic for Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany.
Wesseler C; Department of Thoracic Oncology, Asklepios Klinikum Harburg, Germany.
Hackanson B; Department of Hematology/Oncology, University Medical Center Augsburg, Augsburg, Germany; Department of Medicine I, Freiburg University Hospital, Faculty of Medicine, University of Freiburg, Germany.
Dintner S; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Faehling M; Department of Pneumology, Esslingen Hospital, Germany.
Kuon J; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Department of Thoracic Oncology, Lungenklinik Loewenstein, Germany; German Center for Lung Research (DZL), Germany.
Janning M; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
Kauffmann-Guerrero D; Department of Pneumology - Medical Clinic V, Hospital of the LMU Munich, 80336 Munich, Germany; German Center for Lung Research (DZL), Germany.
Kazdal D; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Kurz S; Department of Pneumology, Protestant Lung Hospital, Berlin, Germany.
Eichhorn F; Thoracic Surgery, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Bozorgmehr F; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Shah R; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Tufman A; Department of Pneumology - Medical Clinic V, Hospital of the LMU Munich, 80336 Munich, Germany; German Center for Lung Research (DZL), Germany.
Wermke M; Clinic for Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany.
Loges S; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
Brueckl WM; Paracelsus Medical University Nuernberg and Department of Respiratory Medicine, Allergology and Sleep Medicine/Nuernberg Lung Cancer Center, Nuernberg General Hospital, 90419, Nuernberg, Germany.
Schulz C; Clinic and Polyclinic for Internal Medicine II, University Hospital Regensburg, 93042 Regensburg, Germany.
Misch D; Department of Pneumology, Helios Klinikum Emil von Behring, Berlin, Germany.
Frost N; Department of Pneumology, Charite University Hospital, Berlin, Germany.
Kollmeier J; Department of Pneumology, Helios Klinikum Emil von Behring, Berlin, Germany.
Reck M; Department of Pneumology, Lungenclinic Großhansdorf, Großhansdorf, Germany; German Center for Lung Research (DZL), Germany.
Griesinger F; Department of Hematology and Oncology, Pius-Hospital, University Dept. of Internal Medicine - Oncology, Oldenburg, Germany.
Grohé C; Department of Pneumology, Protestant Lung Hospital, Berlin, Germany.
Hong JL; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, United States.
Lin HM; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, United States.
Budczies J; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Thomas M; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; German Center for Lung Research (DZL), Germany.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 106-118. Date of Electronic Publication: 2022 May 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
ErbB Receptors*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Tumor Suppressor Protein p53*/genetics
Brain Neoplasms/genetics ; Brain Neoplasms/secondary ; Exons ; Humans ; Mutation ; Platinum/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł :
Prognostic value of CT characteristics in GEP-NET: A systematic review.
Autorzy :
van der Velden DL; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Staal FCR; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Aalbersberg EA; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Castagnoli F; Department of Radiology, University of Brescia, Brescia, Italy.
Wilthagen E; Department of Scientific Administration, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Beets-Tan RGH; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Jul; Vol. 175, pp. 103713. Date of Electronic Publication: 2022 May 20.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Neuroectodermal Tumors, Primitive*
Neuroendocrine Tumors*/diagnostic imaging
Neuroendocrine Tumors*/pathology
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/pathology
Stomach Neoplasms*/pathology
Humans ; Intestinal Neoplasms ; Prognosis ; Retrospective Studies ; Tomography, X-Ray Computed
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Mismatch repair deficiency and MUTYH variants in small intestine-neuroendocrine tumors.
Autorzy :
Helderman NC; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
Elsayed FA; Department of Pathology, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands. Electronic address: f.a.el_.
van Wezel T; Department of Pathology, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands. Electronic address: T.van_.
Terlouw D; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands; Department of Pathology, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands. Electronic address: .
Langers AMJ; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
van Egmond D; Department of Pathology, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands. Electronic address: D.van_.
Kilinç G; Department of Infectious Diseases, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
Hristova H; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
Farina Sarasqueta A; Department of Pathology, Amsterdam University Medical Centre (Location AMC), 1105 AZ Amsterdam, the Netherlands. Electronic address: .
Morreau H; Department of Pathology, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands. Electronic address: .
Nielsen M; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
Suerink M; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, the Netherlands. Electronic address: .
Pokaż więcej
Corporate Authors :
PALGA-group collaborators
Źródło :
Human pathology [Hum Pathol] 2022 Jul; Vol. 125, pp. 11-17. Date of Electronic Publication: 2022 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Colorectal Neoplasms*/genetics
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
DNA Glycosylases*/genetics
Neuroendocrine Tumors*/metabolism
Brain Neoplasms ; DNA Mismatch Repair/genetics ; Germ-Line Mutation ; Humans ; Intestine, Small ; Mismatch Repair Endonuclease PMS2/genetics ; MutL Protein Homolog 1/genetics ; Neoplastic Syndromes, Hereditary
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis.
Autorzy :
Hajjar R; Centre Hospitalier de l'Université de Montréal, Montréal, Canada; Faculté de Médecine, Université de Montréal, Montréal, Canada.
Mercier F; Centre Hospitalier de l'Université de Montréal, Montréal, Canada; Faculté de Médecine, Université de Montréal, Montréal, Canada; Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Passot G; Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Pasquer A; Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Gelli M; Gustave Roussy Institute, Villejuif, France.
Levine EA; Wake Forest University Baptist Medical Center, Winston Salem, United States.
Villeneuve L; Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Poncet G; Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Walter T; Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Glehen O; Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2022 Jul; Vol. 48 (7), pp. 1626-1630. Date of Electronic Publication: 2022 Mar 27.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hyperthermia, Induced*
Neuroendocrine Tumors*/surgery
Peritoneal Neoplasms*/secondary
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Cytoreduction Surgical Procedures/adverse effects ; Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Intestinal Neoplasms ; Pancreatic Neoplasms ; Prospective Studies ; Retrospective Studies ; Stomach Neoplasms ; Survival Rate
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Surgical Resection of a Third Ventricle Nongerminomatous Germ Cell Tumor: Two-Dimensional Operative Video.
Autorzy :
Yang Z; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; National Center for Neurological Disorders, Shanghai, China; Neurosurgical Institute of Fudan University, Shanghai, China; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China; Research Unit of New Technologies of Micro-Endoscopy Combination in Skull Base Surgery (2018RU008), Chinese Academy of Medical Sciences, Shanghai, China.
Zhu T; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; National Center for Neurological Disorders, Shanghai, China; Neurosurgical Institute of Fudan University, Shanghai, China; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China; Research Unit of New Technologies of Micro-Endoscopy Combination in Skull Base Surgery (2018RU008), Chinese Academy of Medical Sciences, Shanghai, China.
Fan Z; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; National Center for Neurological Disorders, Shanghai, China; Neurosurgical Institute of Fudan University, Shanghai, China; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China; Research Unit of New Technologies of Micro-Endoscopy Combination in Skull Base Surgery (2018RU008), Chinese Academy of Medical Sciences, Shanghai, China.
Song J; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; National Center for Neurological Disorders, Shanghai, China; Neurosurgical Institute of Fudan University, Shanghai, China; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China; Research Unit of New Technologies of Micro-Endoscopy Combination in Skull Base Surgery (2018RU008), Chinese Academy of Medical Sciences, Shanghai, China; Department of Neurosurgery, Fujian Campus of National Regional Medical Center, Huashan Hospital, Fudan University, Fuzhou, Fujian, China. Electronic address: .
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2022 Jul; Vol. 163, pp. 1. Date of Electronic Publication: 2022 Mar 30.
Typ publikacji :
Case Reports; Video-Audio Media
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Brain Neoplasms*/surgery
Hydrocephalus*/pathology
Neoplasms, Germ Cell and Embryonal*/diagnostic imaging
Neoplasms, Germ Cell and Embryonal*/pathology
Neoplasms, Germ Cell and Embryonal*/surgery
Pineal Gland*/surgery
Third Ventricle*/diagnostic imaging
Third Ventricle*/surgery
Child ; Coma ; Humans ; Male ; Testicular Neoplasms
SCR Disease Name :
Nonseminomatous germ cell tumor
Raport
Tytuł :
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
Autorzy :
Glaire MA; Cancer Genomics and Immunology Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Ryan NA; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.; Division of Evolution and Genomic Medicine, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, UK.; The Academic Women's Health Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Ijsselsteijn ME; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Kedzierska K; Cancer Genomics and Immunology Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Obolenski S; Cancer Genomics and Immunology Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Ali R; Cancer Genomics and Immunology Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.; Department of Obstetrics and Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
de Miranda NF; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Church DN; Cancer Genomics and Immunology Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Oxford Cancer Centre, Churchill Hospital, Oxford University Hospitals Foundation NHS Trust, Oxford, UK.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Pokaż więcej
Źródło :
The Journal of pathology [J Pathol] 2022 Jul; Vol. 257 (3), pp. 340-351. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Colorectal Neoplasms*/pathology
Endometrial Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Brain Neoplasms ; CD8-Positive T-Lymphocytes/pathology ; DNA Mismatch Repair/genetics ; Female ; Humans ; Immunity ; Microsatellite Instability ; Neoplastic Syndromes, Hereditary ; Prognosis
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies